Author:
Cozza G.,Fortuna M.,Meggio F.,Sarno S.,Kubbutat M. H. G.,Totzke F.,Schaechtele C.,Pinna L. A.,Olsufyeva E. N.,Preobrazhenskaya M. N.
Subject
Biochemistry,General Medicine
Reference29 articles.
1. Fabbro, D., Cowan-Jacob, S. W., and Moebitz, H. (2015) Ten things you should know about protein kinases, Br. J. Pharmacol., 172, 2675–2700.
2. Shchemelinin, I., Sefc, L., and Necas, E. (2006) Protein kinase inhibitor, Folia Biol. (Prague), 52, 137–148.
3. Leader, D. (1993) Viral protein kinases and protein phosphatases, Pharmacol. Ther., 59, 343–389.
4. Mohr, E. L., McMullan, L. K., Lo, M. K., Spengler, J. R., Bergeron, E., Albarico, C. G., Shrivastava-Ranjan, P., Chiang, C.-F., Nichol, S. T., Spiropoulou, C. F., and Flint, M. (2015) Inhibitors of cellular kinases with broad-spec-trum antiviral activity for hemorrhagic fever viruses, Antiviral Res., 120, 40–47.
5. Chao, S.-H., and Price, D. H. (2001) Flavopiridol (L86-8275, HMR1275) is a cyclin-dependent kinase (Cdk) inhibitor in clinical trials as a cancer therapy that has been recently shown to block human immunodeficiency virus, J. Biol. Chem., 276, 31793–31799.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献